Filing Details
- Accession Number:
- 0000950170-24-134522
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-09 16:09:30
- Reporting Period:
- 2024-12-05
- Accepted Time:
- 2024-12-09 16:09:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1420565 | Aileron Therapeutics Inc. | ALRN | Pharmaceutical Preparations (2834) | 134196017 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1790933 | Brian James Windsor | C/O Aileron Therapeutics, Inc. 12407 N. Mopac Expy. Suite 250 #390 Austin TX 78758 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-05 | 239 | $2.24 | 239 | No | 4 | P | Indirect | By son |
| Common Stock | Acquisiton | 2024-12-05 | 161 | $2.25 | 161 | No | 4 | P | Indirect | By son |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By son |
| No | 4 | P | Indirect | By son |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 7,122 | Direct | |
| Common Stock | 225 | Indirect | By son |
Footnotes
- The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
